Skip to content

Clinical trials

Phase 2 Retinal Vein Occlusion trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20041
20092
20101
20153
20171
20192
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Manhattan Eye, Ear & Throat Hospital2
Aerie Pharmaceuticals1
Aerpio Therapeutics1
Alimera Sciences1
Allergan1
Annexin Pharmaceuticals AB1
Barnes Retina Institute1
Clearside Biomedical, Inc.1
EyeBiotech Ltd.1
Eyetech Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion16
Macular Edema7
Diabetic Retinopathy4
Macular Degeneration3
Wet Macular Degeneration2
Communicable Diseases1
Diabetes Mellitus1
Geographic Atrophy1
Retinal Diseases1
Uveitis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.